Institutional Manager · CIK 0001601086
ARMISTICE CAPITAL, LLC
NEW YORK, NY · File #028-16738
Latest AUM
$8.40B
Positions
370
Top-10 Concentration
70.5%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| ADD | SPDR S&P 500 ETF TR | SPY | +300,000 | +$204.6M | +$23.6M |
| REDUCE | IMMUNOVANT INC | IMVT | -5,586,000 | -$142.0M | +$54.3M |
| REDUCE | TRAVERE THERAPEUTICS INC | TVTX | -2,960,109 | -$113.1M | +$96.2M |
| REDUCE | ISHARES TR | 464287655 | -400,000 | -$98.5M | +$16.8M |
| NEW | KENVUE INC | KVUE | +3,992,196 | +$68.9M | $0 |
| ADD | AGIOS PHARMACEUTICALS INC | AGIO | +2,236,000 | +$60.9M | -$9.9M |
| EXITED | EXACT SCIENCES ORD | 30063P105 | -1,030,465 | -$56.4M | $0 |
| NEW | GSK PLC | GLAXF | +1,000,000 | +$49.0M | $0 |
| REDUCE | CYTOKINETICS INC | CYTK | -696,868 | -$44.3M | +$10.3M |
| ADD | E L F BEAUTY INC | ELF | +525,018 | +$39.9M | -$7.5M |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 2025370 pos · $8.40B
- 13F HOLDINGS REPORTQ/E Sep 2025332 pos · $6.74B
- 13F HOLDINGS REPORTQ/E Jun 2025210 pos · $5.80B
- 13F HOLDINGS REPORTQ/E Mar 2025230 pos · $6.67B
- 13F HOLDINGS REPORTQ/E Dec 2024232 pos · $7.33B
- 13F HOLDINGS REPORTQ/E Sep 2024259 pos · $6.25B
- 13F HOLDINGS REPORTQ/E Jun 2024254 pos · $7.95B
- 13F HOLDINGS REPORTQ/E Mar 2024337 pos · $7.54B
- 13F HOLDINGS REPORTQ/E Dec 2023254 pos · $6.53B
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | SPY | 1,800,000 | $1.23B | 17.64% |
| 2 | ISHARES TR | 464287655 | 4,500,000 | $1.11B | 15.91% |
| 3 | ISHARES TR | 464287655 | 3,600,000 | $886.2M | 12.73% |
| 4 | SPDR S&P 500 ETF TR | SPY | 1,200,000 | $818.3M | 11.76% |
| 5 | PTC THERAPEUTICS INC | PTCT | 2,801,869 | $212.8M | 3.06% |
| 6 | IMMUNOVANT INC | IMVT | 5,747,155 | $146.1M | 2.10% |
| 7 | TRAVERE THERAPEUTICS INC | TVTX | 3,763,891 | $143.8M | 2.07% |
| 8 | SUPERNUS PHARMACEUTICALS INC | SUPN | 2,764,000 | $137.4M | 1.97% |
| 9 | NEUROCRINE BIOSCIENCES INC | NBIX | 820,240 | $116.3M | 1.67% |
| 10 | INCYTE CORP | INCY | 1,098,102 | $108.5M | 1.56% |
| 11 | AMAZON COM INC | AMZN | 367,633 | $84.9M | 1.22% |
| 12 | DENTSPLY SIRONA INC | XRAY | 7,298,000 | $83.4M | 1.20% |
| 13 | AGIOS PHARMACEUTICALS INC | AGIO | 3,036,000 | $82.6M | 1.19% |
| 14 | AGIOS PHARMACEUTICALS INC | AGIO | 3,000,000 | $81.7M | 1.17% |
| 15 | FRESHPET INC | FRPT | 1,296,000 | $79.0M | 1.13% |
| 16 | MADRIGAL PHARMACEUTICALS INC | MDGL | 120,000 | $69.9M | 1.00% |
| 17 | KENVUE INC | KVUE | 3,992,196 | $68.9M | 0.99% |
| 18 | GE HEALTHCARE TECHNOLOGIES I | GEHC | 792,000 | $65.0M | 0.93% |
| 19 | REGENERON PHARMACEUTICALS | REGN | 84,000 | $64.8M | 0.93% |
| 20 | DYNE THERAPEUTICS INC | DYN | 3,249,708 | $63.6M | 0.91% |